Zions Bancorporation’s Astrana Health ASTH Stock Holding History

Zions Bancorporation’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3,125	Closed	-$56K	–	1046
2020 Q3	$56K	Buy	+3,125	New	+$53.9K	0.01%	355

Other funds holding ASTH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Zions Bancorporation's ASTH Position: Q4 2020 in Review

Zions Bancorporation sold out of Astrana Health (ASTH) in Q4 2020, closing a stake of 3,125 shares — an estimated $56K sold.

Zions Bancorporation first reported a position in ASTH in Q3 2020 and held it in 1 quarter. The position peaked at $56K in Q3 2020. 62 funds tracked by Wall St. Rank hold ASTH as of Q4 2020.

Zions Bancorporation reported no remaining Astrana Health position as of Q4 2020 after selling out during the quarter.
Zions Bancorporation sold 3,125 Astrana Health shares in Q4 2020, an estimated $56K.
Zions Bancorporation first reported a position in Astrana Health in Q3 2020 and held it in 1 quarter.
Zions Bancorporation's Astrana Health position peaked at $56K in Q3 2020.
62 funds tracked by Wall St. Rank held Astrana Health as of Q4 2020.

Based on Zions Bancorporation's 13F filing for Q4 2020, filed 12 Feb 2021.